Mannatech, Incorporated (NASDAQ:MTEX – Get Free Report) Director Larry Jobe bought 5,000 shares of the business’s stock in a transaction on Tuesday, May 19th. The stock was purchased at an average cost of $4.20 per share, with a total value of $21,000.00. Following the purchase, the director owned 67,197 shares of the company’s stock, valued at $282,227.40. This represents a 8.04% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Mannatech Stock Down 1.1%
Shares of MTEX opened at $4.37 on Friday. The firm has a market cap of $8.43 million, a P/E ratio of -0.65 and a beta of 0.61. The stock has a 50 day simple moving average of $5.48 and a two-hundred day simple moving average of $7.22. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.09 and a quick ratio of 0.59. Mannatech, Incorporated has a 1 year low of $3.80 and a 1 year high of $12.45.
Mannatech (NASDAQ:MTEX – Get Free Report) last issued its earnings results on Thursday, May 14th. The company reported $0.49 earnings per share (EPS) for the quarter. The business had revenue of $24.92 million during the quarter. Mannatech had a negative return on equity of 2,383.34% and a negative net margin of 11.97%.
Mannatech Company Profile
Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.
The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.
Read More
- Five stocks we like better than Mannatech
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
